Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021
Data to highlight the safety, tolerability and efficacy of LUPKYNIS in patients with lupus nephritis VICTORIA, BC – Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a biopharma company committed… Read More




